Cite
HARVARD Citation
Ghaffarpour, N. et al. (n.d.). Patients with lymphatic malformations who receive the immunostimulant OK‐432 experience excellent long‐term outcomes. Acta pædiatrica. pp. 1169-1173. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ghaffarpour, N. et al. (n.d.). Patients with lymphatic malformations who receive the immunostimulant OK‐432 experience excellent long‐term outcomes. Acta pædiatrica. pp. 1169-1173. [Online].